Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer

We conducted a prospective, observational study of aspirin and COX-2 inhibitor use and survival in stage III colon cancer patients enrolled in an adjuvant chemotherapy trial. Among 799 eligible patients, aspirin use was associated with improved recurrence-free survival (RFS) (multivariable hazard ra...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Natl Cancer Inst
Auteurs principaux: Ng, Kimmie, Meyerhardt, Jeffrey A., Chan, Andrew T., Sato, Kaori, Chan, Jennifer A., Niedzwiecki, Donna, Saltz, Leonard B., Mayer, Robert J., Benson, Al B., Schaefer, Paul L., Whittom, Renaud, Hantel, Alexander, Goldberg, Richard M., Venook, Alan P., Ogino, Shuji, Giovannucci, Edward L., Fuchs, Charles S.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2014
Sujets:
Brief Communication
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4271076/
https://ncbi.nlm.nih.gov/pubmed/25432409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju345
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires